Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Pathol Oncol Res ; 24(4): 885-890, 2018 Oct.
Article in English | MEDLINE | ID: mdl-28913610

ABSTRACT

Eukaryotic elongation factor 2 (eEF2), a key regulator of protein synthesis, is involved in the progression of several types of cancer. This first study was to investigate the relationships between eEF2 protein and prostate cancer (PCa). Immunohistochemical staining was used to verify eEF2 protein in a set of 97 formalin-fixed, paraffin-embedded primary PCa tissues. Expression of eEF2 protein in positive cells was characterized by cytoplasmic staining. Correlations with clinicopathological factors were evaluated by Chi-square or Fisher's exact probability tests. eEF2 protein was found in 74 out of 97 (76.29%) patients. eEF2-positive had higher PSA and Gleason score than negative in all patients. In addition, the positive expression of eEF2 protein was significantly associated with PSA and Gleason score (P = 0.007 and 0.002). However, no significant correlations occurred between expression of eEF2 protein and TNM stage (P = 0.292). In those eEF2 protein-positive patients, we have found staining intensity of eEF2 protein was not only associated with PSA and Gleason score, but also associated with TNM stage (P = 0, 0.014 and 0.001, respectively). To conclude, our study indicates that expression of eEF2 protein is a potential biomarker for evaluating PCa.


Subject(s)
Adenocarcinoma/diagnosis , Biomarkers, Tumor/analysis , Peptide Elongation Factor 2/biosynthesis , Prostatic Neoplasms/diagnosis , Adenocarcinoma/pathology , Aged , Aged, 80 and over , Humans , Male , Middle Aged , Peptide Elongation Factor 2/analysis , Prostatic Neoplasms/pathology
2.
J Neurochem ; 117(5): 841-55, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21426346

ABSTRACT

Long-term facilitation (LTF) in Aplysia is a leading model for elucidating the biochemical mechanisms of synaptic plasticity underlying learning. LTF requires translational control downstream of target of rapamycin complex 1. Our lab has previously shown that treatment with the facilitating neurotransmitter, 5-hydroxytryptamine (5-HT), causes a target of rapamycin complex 1-mediated decrease in phosphorylation of eukaryotic elongation factor 2 (eEF2) within the neurites of sensory neurons involved in LTF. Here, we characterize the Aplysia orthologue of eEF2 kinase (eEF2K). We show that the Aplysia eEF2K orthologue contains an S6 kinase phosphorylation site and that a serine-to-alanine mutation at this site blocks the ability of 5-HT to decrease eEF2 phosphorylation in neurites. We also show that within the soma, 5-HT has the opposite effect, decreasing eEF2K phosphorylation at the S6 kinase site and, concomitantly, increasing eEF2 phosphorylation. Surprisingly, while eEF2K over-expression inhibits translation of a marker for internal ribosome entry site-dependent translation, it stimulates the translation of a marker for cap-dependent translation. This study demonstrates that eEF2 is differentially regulated in separate compartments and contributes to a growing body of evidence that inhibition of elongation can stimulate the translation of certain transcripts.


Subject(s)
Elongation Factor 2 Kinase/biosynthesis , Peptide Elongation Factor 2/biosynthesis , Sensory Receptor Cells/metabolism , Animals , Aplysia , Blotting, Western , Caenorhabditis elegans Proteins/genetics , Cells, Cultured , Cloning, Molecular , Elongation Factor 2 Kinase/genetics , Gene Expression Regulation/physiology , Humans , Immunohistochemistry , Microscopy, Fluorescence , Neurites/drug effects , Peptide Elongation Factor 2/genetics , Phosphorylation , Protein Biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Ribosomal Protein S6 Kinases/genetics , Ribosomal Protein S6 Kinases/metabolism , Serotonin/pharmacology , Transcription Factors/genetics
3.
J Appl Physiol (1985) ; 106(4): 1412-8, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19112158

ABSTRACT

The molecular mechanisms by which resistance exercise enlarges muscle mass, particularly the mass of fast-twitch type II fibers, are likely to involve enhanced phosphorylation/activation of key enzymes regulating protein synthesis. The hypothesis is that resistance exercise influences the phosphorylation of such key signaling proteins to a greater extent in type II than in type I fibers. Six recreationally active male subjects performed four sets of six maximal lengthening contractions with one leg. Muscle biopsies were taken from the vastus lateralis before and immediately after exercise and following 1 and 2 h of recovery. Samples were freeze-dried, and individual muscle fibers were dissected out and identified as type I or type II after staining for myosin ATPase. Phosphorylation of p70(S6k) on Thr(389) and S6 in type II fibers was increased three-to fourfold and six- to ninefold (P < 0.05), respectively, 1 and 2 h after exercise, whereas phosphorylation in type I fibers remained unchanged. Phosphorylation of Akt, mammalian target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) was unaltered in both fiber types, whereas that of eukaryotic elongation factor 2 (eEF2) was attenuated 20-45% (P < 0.05) in type II fibers during recovery. Phosphorylation of ERK1/2 was elevated six- to sevenfold (P < 0.05) immediately after exercise, and p38 MAPK phosphorylation was increased three- to fourfold (P < 0.05) for as long as 1 h after exercise in both types of fibers, although the level was markedly higher in type II fibers (P < 0.05). In conclusion, the elevation of p70(S6k) and the reduction of eEF2 phosphorylation in the type II fibers following resistance exercise suggest stimulation of protein synthesis, which may contribute to a more pronounced enlargement of these fibers. Our findings also suggest that p70(S6k) is activated, at least in part, via pathways not involving Akt-mTOR and MAPK.


Subject(s)
Muscle Contraction/physiology , Muscle Fibers, Fast-Twitch/physiology , Muscle Fibers, Slow-Twitch/physiology , Muscle, Skeletal/physiology , Adult , Blotting, Western , Cyclic AMP-Dependent Protein Kinases/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , Humans , Male , Muscle, Skeletal/cytology , Myosin Heavy Chains/metabolism , Oncogene Protein v-akt/biosynthesis , Oncogene Protein v-akt/genetics , Peptide Elongation Factor 2/biosynthesis , Phosphorylation , Protein Kinases/biosynthesis , Protein Kinases/genetics , Ribosomal Protein S6 Kinases, 70-kDa/biosynthesis , Ribosomal Protein S6 Kinases, 70-kDa/genetics , Signal Transduction/physiology , TOR Serine-Threonine Kinases , p38 Mitogen-Activated Protein Kinases/metabolism
4.
Proteomics ; 8(17): 3469-85, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18683816

ABSTRACT

Tyrosine kinase 2 (Tyk2) belongs to the Janus kinase (Jak) family and is involved in signalling via a number of cytokines. Tyk2-deficient mice are highly resistant to lipopolysaccharide (LPS)-induced endotoxin shock. Macrophages are key players in the pathogenesis of endotoxin shock and, accordingly, defects in the LPS responses of Tyk2(-/-) macrophages have been reported. In the present study, the molecular role of Tyk2 is investigated in more detail using a proteomics approach. 2-D DIGE was applied to compare protein patterns from wild-type and Tyk2(-/-) macrophages and revealed significant differences in protein expression patterns between the genotypes before and after LPS treatment. Twenty-one proteins deriving from 25 differentially expressed spots were identified by MALDI/ESI MS. Among them, we show for N-myc interactor that its mRNA transcription/stability is positively influenced by Tyk2. In contrast, LPS-induced expression of plasminogen activator 2 protein but not mRNA is strongly enhanced in the absence of Tyk2. Our data furthermore suggest an influence of Tyk2 on the subcellular distribution of elongation factor 2 and on LPS-mediated changes in the peroxiredoxin 1 spot pattern. Thus, our results imply regulatory roles of Tyk2 at multiple levels and establish novel connections between Tyk2 and several cellular proteins.


Subject(s)
Lipopolysaccharides/pharmacology , Macrophages/drug effects , Macrophages/metabolism , Proteome/drug effects , TYK2 Kinase/physiology , Animals , Cell Cycle Proteins/biosynthesis , Electrophoresis, Gel, Two-Dimensional , Female , Intracellular Signaling Peptides and Proteins , Male , Mice , Mice, Knockout , Peptide Elongation Factor 2/biosynthesis , Peroxiredoxins/biosynthesis , Plasminogen Activator Inhibitor 2/biosynthesis , RNA, Messenger/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , TYK2 Kinase/deficiency
5.
DNA Seq ; 19(1): 1-7, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18300156

ABSTRACT

We have identified a developmentally regulated gene translation elongation factor 2 (EF-2) in zebrafish (GenBank Accession No. AAQ91234). Analysis of DNA sequence of zebrafish EF-2 shows that the 2826 bp cDNA spans an open reading frame from nucleotide 55 to 2631 and encodes a protein of 858 amino acids. It shares an identity of 92, 93, 93, 92, 79 and 80% in amino acid sequence to human, mouse, Chinese hamster, Gallus gullus, C. elegans and Drosophila EF-2, respectively. Zebrafish EF-2 protein has 16 conserved domains, GTP-binding domain is found in the NH2 terminus, and the ADP-ribosylation domain locates at the COOH terminus. Whole mount in situ hybridization on zebrafish embryos shows that the transcripts of EF-2 gene are detected during the early development of zebrafish embryo and constantly change from 5-somite stage to protruding-mouth stage. It expresses strongly throughout envelope at 5-somite stage. Then the stained cells concentrate strongly in the eyes, brain and muscle tissue. From prim-25 stage the stained cells only appear strongly in the lens and the anterior portion of the cerebellum.


Subject(s)
Gene Expression Regulation, Developmental , Peptide Elongation Factor 2/biosynthesis , Peptide Elongation Factor 2/genetics , Zebrafish Proteins/biosynthesis , Zebrafish Proteins/genetics , Zebrafish/genetics , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , Cricetinae , Humans , Mice , Molecular Sequence Data , Transcription, Genetic , Zebrafish/embryology
6.
Gene ; 386(1-2): 183-90, 2007 Jan 15.
Article in English | MEDLINE | ID: mdl-17118580

ABSTRACT

Elongation factor 2 (EF-2) plays a key role in the essential process of protein synthesis by translocating tRNAs from the ribosomal A- and P-sites to the P- and E-sites. EF-2 regulates the outcome of protein synthesis in mammalian cells. This report demonstrates that chicken EF-2 protein levels are dependent on transcription in 8-bromo-cAMP, insulin and phorbol ester-treated cells. In order to delineate functional domains that control chicken EF-2 gene transcription, the 5'-flanking region of the chicken EF-2 promoter was analyzed. Deletion constructs from -550 and -86 had the same basal level promoter activity as the whole EF-2 promoter. The sequence between nucleotides -700 and -550 was determined to be a regulatory region for the chicken EF-2 basal promoter activity. The region between -700 and -550 has a negative regulatory region and two regulatory proteins (I, II). 8-bromo-cAMP increased chicken EF-2 promoter activity (-700/+102) in Rat 1 HIR fibroblast cells more than insulin and phorbol ester treatment. Binding of protein I and II were decreased by 8-bromo-cAMP but restored by a protein kinase A inhibitor (KT5720). GATA consensus sequence oligonucleotide and fragment -86/-50 prevented protein II binding of fragment -700/-550. This result suggested that protein II is a GATA-like protein. These observations provide a novel regulatory mechanism for the EF-2 promoter.


Subject(s)
Chickens/genetics , Peptide Elongation Factor 2/genetics , Promoter Regions, Genetic/physiology , 5' Untranslated Regions/genetics , Animals , Base Sequence , Binding Sites/genetics , Cell Line , GATA1 Transcription Factor/physiology , Molecular Sequence Data , Peptide Elongation Factor 2/biosynthesis , Peptide Elongation Factor 2/physiology , Rats
7.
Int J Dev Biol ; 50(4): 399-403, 2006.
Article in English | MEDLINE | ID: mdl-16525935

ABSTRACT

We have identified translation elongation factor 2 (EF-2) in zebrafish (GenBank Accession No. AAQ91234). Analysis of the DNA sequence of zebrafish EF-2 shows that the 2826 bp cDNA spans an open reading frame between nucleotide 55 to 2631 and encodes a protein of 858 amino acids. Zebrafish EF-2 protein shares 92%, 93%, 93% and 92% identity with the corresponding amino acid sequence in human, mouse, Chinese hamster and Gallus EF-2, respectively. Whole-mount in situ hybridization showed that zebrafish EF-2 was a developmentally regulated gene and might play important roles during the early development of zebrafish embryos. Therefore, we further studied the function of EF-2 during early embryogenesis. Using morpholino antisense oligo knockdown assays, anti-MO injected embryos were found to display abnormal development. The yolk balls were larger than normal and the melanophores spreading on their bodies became fewer. Furthermore, their tails were incurvate and their lenses were much smaller than those of the normal embryos. However the EF-2 overexpression data showed that extra EF-2 protein had no obvious effect on zebrafish embryonic development.


Subject(s)
Gene Expression Regulation, Developmental/physiology , Peptide Elongation Factor 2/biosynthesis , Peptide Elongation Factor 2/genetics , Zebrafish/genetics , Amino Acid Sequence , Animals , Cloning, Molecular , Humans , In Situ Hybridization , Molecular Sequence Data , Morpholinos , Oligodeoxyribonucleotides/pharmacology , Oligonucleotides, Antisense/pharmacology , Peptide Elongation Factor 2/deficiency , Peptide Elongation Factor 2/physiology , Zebrafish/embryology , Zebrafish/physiology
8.
J Cell Biochem ; 94(3): 497-507, 2005 Feb 15.
Article in English | MEDLINE | ID: mdl-15534876

ABSTRACT

High continuous hydrostatic pressure is known to inhibit the total cellular protein synthesis. In this study, our goal was to identify pressure-regulated proteins by using two dimensional gel electrophoresis and mass spectrometry. This analysis showed that under 30 MPa continuous hydrostatic pressure the biosynthesis of eukaryotic elongation factor-2 (eEF-2) was inhibited both in HeLa carcinoma and T/C28a4 chondrocytic cell lines. Western blot analysis of HeLa cells revealed that the cellular protein level of eEF-2 decreased by 40%-50% within 12 h of the pressure treatment. However, the steady-state mRNA level of eEF-2 was not affected by the pressure. Cycloheximide addition after 4 h-pressure treatment suggested that the half-life of eEF-2 protein was shorter in pressurized cells. eEF-2 is responsible for the translocation of ribosome along the specific mRNA during translation, and its phosphorylation prevents the ribosomal translocation. Therefore, increased phosphorylation of eEF-2 was considered as one mechanism that could explain the reduced level of protein synthesis in pressurized HeLa cell cultures. However, Western blot analysis with an antibody recognizing the Thr56-phosphorylated form of eEF-2 showed that phosphorylation of eEF-2 was not elevated in pressurized samples. In conclusion, the inhibition of protein synthesis under high pressure occurs independent of the phosphorylation of eEF-2. However, this inhibition may result from the decrease of cellular eEF-2 protein.


Subject(s)
Peptide Elongation Factor 2/biosynthesis , Amino Acid Sequence , Base Sequence , Blotting, Northern , Blotting, Western , DNA Primers , Electrophoresis, Gel, Two-Dimensional , Eukaryotic Cells/metabolism , HeLa Cells , Humans , Molecular Sequence Data , Peptide Elongation Factor 2/chemistry , Peptide Elongation Factor 2/metabolism , Phosphorylation , Pressure , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
9.
Biochemistry ; 41(50): 14879-84, 2002 Dec 17.
Article in English | MEDLINE | ID: mdl-12475236

ABSTRACT

Fusidic acid (FA) and helvolic acid (HA) belong to a small family of naturally occurring steroidal antibiotics known as fusidanes. FA was studied for its ability to alter the biochemical properties supported by elongation factor 2 isolated from the archaeon Sulfolobus solfataricus (SsEF-2). Both poly(Phe) synthesis and ribosome-dependent GTPase (GTPase(r)) were progressively impaired by increasing concentrations of FA up to 1 mM, whereas no effect was measured in the intrinsic GTPase of SsEF-2 triggered by ethylene glycol in the presence of barium chloride (GTPase(g)). The highest antibiotic concentration caused inhibition of either poly(Phe) synthesis or GTPase(r) only slightly above 50%. A greater response of SsEF-2 was observed when HA was used instead of FA. HA caused even a weak impairment of GTPase(g). A mutated form of SsEF-2 carrying the L452R substitution exhibited an increased sensitivity to fusidane inhibition in either poly(Phe) synthesis or GTPase(r). Furthermore, both FA and HA were able to cause impairment of GTPase(g). The antibiotic concentrations leading to 50% inhibition (IC(50)) indicate that increased fusidane responsiveness due to the use of HA or the L452R amino acid replacement is mutually independent. However, their combined effect decreased the IC(50) up to 0.1 mM. Despite the difficulties in reaching complete inhibition of the translocation process in S. solfataricus, these findings suggest that fusidane sensibility is partially maintained in the archaeon S. solfataricus. Therefore, it is likely that SsEF-2 harbors the structural requirements for forming complexes with fusidane antibiotics. This hypothesis is further evidenced by the observed low level of impairment of GTPase(g), a finding suggesting a weak direct interaction between the archaeal factor and fusidanes even in the absence of the ribosome. However, the ribosome remains essential for the sensitivity of SsEF-2 toward fusidane antibiotics.


Subject(s)
Archaeal Proteins/antagonists & inhibitors , Fusidic Acid/analogs & derivatives , Fusidic Acid/chemistry , Peptide Elongation Factor 2/antagonists & inhibitors , Protein Synthesis Inhibitors/chemistry , Sulfolobus/chemistry , Sulfolobus/metabolism , Amino Acid Substitution/genetics , Archaeal Proteins/biosynthesis , Archaeal Proteins/genetics , Arginine/genetics , Drug Resistance, Microbial , Leucine/genetics , Mutagenesis, Site-Directed , Peptide Elongation Factor 2/biosynthesis , Peptide Elongation Factor 2/genetics , Sulfolobus/genetics
10.
Eur J Neurosci ; 16(6): 1037-44, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12383232

ABSTRACT

Zinc released from a subpopulation of glutamatergic synapses, mainly localized in the cerebral cortex and the hippocampus, facilitates or reduces glutamatergic transmission by acting on neuronal AMPA and NMDA receptors, respectively. However, neurons are not the only targets of zinc. In the present study, we provide evidence that zinc inhibits protein synthesis in cultured astrocytes from the cerebral cortex of embryonic mice. This inhibition, which reached 85% in the presence of 100 micro m zinc, was partially and slowly reversible and resulted from the successive inhibition of the elongation and the initiation steps of the protein translation process. This was assessed by measuring the phosphorylation level of the elongation factor eEF-2 and of the alpha subunit of the initiation factor eIF-2. Due to the rapid turnover of connexin-43 that forms junction channels in cultured astrocytes, the zinc-induced decrease of protein synthesis led to a partial disappearance of connexin-43, which was associated with an inhibition of the cellular coupling in the astrocytic syncitium. In conclusion, zinc not only inhibits protein synthesis in neurons, as previously demonstrated, but also in astrocytes. The resulting decrease in the intercellular communication between astrocytes should alter the function of surrounding neurons as well as their survival.


Subject(s)
Astrocytes/metabolism , Cell Communication/physiology , Cerebral Cortex/metabolism , Connexin 43/biosynthesis , Neurons/metabolism , Protein Biosynthesis/physiology , Zinc/metabolism , Animals , Astrocytes/drug effects , Cell Communication/drug effects , Cells, Cultured , Cerebral Cortex/drug effects , Connexin 43/drug effects , DNA-Binding Proteins/biosynthesis , DNA-Binding Proteins/drug effects , Dose-Response Relationship, Drug , Female , Fetus , Intercellular Junctions/drug effects , Intercellular Junctions/metabolism , Ionophores/pharmacology , Mice , Neurons/drug effects , Peptide Elongation Factor 2/biosynthesis , Peptide Elongation Factor 2/drug effects , Pregnancy , Protein Biosynthesis/drug effects , Transcription Factors/biosynthesis , Transcription Factors/drug effects , Zinc/pharmacology
11.
Am J Physiol Heart Circ Physiol ; 281(1): H161-7, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11406481

ABSTRACT

Increased protein synthesis is the cardinal feature of cardiac hypertrophy. We have studied angiotensin II (ANG II)-dependent regulation of eukaryotic elongation factor-2 (eEF-2), an essential component of protein translation required for polypeptide elongation, in rat neonatal cardiac myocytes. eEF2 is fully active in its dephosphorylated state and is inhibited following phosphorylation by eEF2 kinase. ANG II treatment (10(-10) - 10(-7) M) for 30 min produced an AT(1) receptor-specific and concentration- and time-dependent reduction in the phosphorylation of eEF-2. Protein phosphatase 2A (PP2A) inhibitors okadaic acid and fostriecin, but not the PP2B inhibitor FK506, attenuated ANG II-dependent dephosphorylation of eEF-2. ANG II activated mitogen-activated protein kinase, (MAPK) within 10 min of treatment, and blockade of MAPK activation with PD-98059 (1--20 nM) inhibited eEF-2 dephosphorylation. The effect of ANG II on eEF-2 dephosphorylation was also blocked by LY-29004 (1-20 nM), suggesting a role for phosphoinositide 3-kinase, but the mammalian target rapamycin inhibitor rapamycin (10--100 nM) had no effect. Together these results suggest that the ANG II-dependent increase in protein synthesis includes activation of eEF-2 via dephosphorylation by PP2A by a process that involves both PI3K and MAPK.


Subject(s)
Angiotensin II/pharmacology , Myocardium/metabolism , Peptide Elongation Factor 2/metabolism , Angiotensin II/physiology , Animals , Cells, Cultured , Chromones/pharmacology , Enzyme Inhibitors/pharmacology , Mitogen-Activated Protein Kinases/physiology , Morpholines/pharmacology , Myocardium/cytology , Peptide Elongation Factor 2/biosynthesis , Phosphoprotein Phosphatases/physiology , Phosphorylation/drug effects , Protein Biosynthesis , Protein Phosphatase 2 , Rats , Rats, Sprague-Dawley , Receptor, Angiotensin, Type 1 , Receptor, Angiotensin, Type 2 , Receptors, Angiotensin/physiology , Signal Transduction/physiology , Sirolimus/pharmacology
12.
Microbiology (Reading) ; 147(Pt 2): 383-390, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11158355

ABSTRACT

The sordarin class of natural products selectively inhibits fungal protein synthesis by impairing the function of eukaryotic elongation factor 2 (eEF2). Mutations in Saccharomyces cerevisiae eEF2 or the ribosomal stalk protein rpP0 can confer resistance to sordarin, although eEF2 is the major determinant of sordarin specificity. It has been shown previously that sordarin specifically binds S. cerevisiae eEF2 while there is no detectable binding to eEF2 from plants or mammals, despite the high level of amino acid sequence conservation among these proteins. In both whole-cell assays and in vitro translation assays, the efficacy of sordarin varies among different species of pathogenic fungi. To investigate the basis of sordarin's fungal selectivity, eEF2 has been cloned and characterized from several sordarin-sensitive and -insensitive fungal species. Results from in vivo expression of Candida species eEF2s in S. cerevisiae and in vitro translation and growth inhibition assays using hybrid S. cerevisiae eEF2 proteins demonstrate that three amino acid residues within eEF2 account for the selectivity of this class of compounds. It is also shown that the corresponding residues at these positions in human eEF2 are sufficient to confer sordarin insensitivity to S. cerevisiae identical to that observed with mammalian eEF2.


Subject(s)
Antifungal Agents/pharmacology , Candida/drug effects , Peptide Elongation Factor 2/antagonists & inhibitors , Peptide Elongation Factor 2/biosynthesis , Amino Acid Sequence , Candida/classification , Candida/genetics , Candida/growth & development , Candida/metabolism , Cloning, Molecular , Fungal Proteins/biosynthesis , Humans , Indenes , Molecular Sequence Data , Peptide Elongation Factor 2/chemistry , Peptide Elongation Factor 2/genetics , Protein Biosynthesis , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae/metabolism , Sequence Analysis, DNA , Species Specificity
13.
Acta Biochim Pol ; 47(1): 113-20, 2000.
Article in English | MEDLINE | ID: mdl-10961684

ABSTRACT

Pentamidine despite its rather high toxicity, is currently in clinical use. For development of new drugs of this type it is important to know the mechanism of their action. Two new amidines (I and II) and 4',6-diamidino-2-phenylindole (DAPI) were found in preliminary experiments to inhibit protein synthesis in vitro in the cell-free rat liver system. The three compounds differed in the precise mode of action. The inhibitory effect of I on the activity of the eukaryotic elongation factor eEF-2 and ribosomes seems to suggest that the binding site of eEF-2 on the ribosome was blocked by this compound. eEF-2 has been identified as the primary target of II and eEF-1 as the primary target of DAPI in the system studied.


Subject(s)
Pentamidine/analogs & derivatives , Peptide Elongation Factor 2/biosynthesis , Animals , Magnetic Resonance Spectroscopy , Pentamidine/pharmacology , Peptide Elongation Factor 2/metabolism , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...